114 related articles for article (PubMed ID: 7826209)
21. Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand.
Sailaja G; Husain S; Nayak BP; Jabbar AM
J Immunol; 2003 Mar; 170(5):2496-507. PubMed ID: 12594275
[TBL] [Abstract][Full Text] [Related]
22. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1.
Labrijn AF; Poignard P; Raja A; Zwick MB; Delgado K; Franti M; Binley J; Vivona V; Grundner C; Huang CC; Venturi M; Petropoulos CJ; Wrin T; Dimitrov DS; Robinson J; Kwong PD; Wyatt RT; Sodroski J; Burton DR
J Virol; 2003 Oct; 77(19):10557-65. PubMed ID: 12970440
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
Berger EA; Lifson JD; Eiden LE
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455
[TBL] [Abstract][Full Text] [Related]
24. CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5.
Raja A; Venturi M; Kwong P; Sodroski J
J Virol; 2003 Jan; 77(1):713-8. PubMed ID: 12477875
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120.
DeVico AL; Rahman R; Welch J; Crowley R; Lusso P; Sarngadharan MG; Pal R
Virology; 1995 Aug; 211(2):583-8. PubMed ID: 7544051
[TBL] [Abstract][Full Text] [Related]
26. Janusin: new molecular design for bispecific reagents.
Traunecker A; Lanzavecchia A; Karjalainen K
Int J Cancer Suppl; 1992; 7():51-2. PubMed ID: 1428404
[TBL] [Abstract][Full Text] [Related]
27. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody.
Ho DD; Fung MS; Cao YZ; Li XL; Sun C; Chang TW; Sun NC
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8949-52. PubMed ID: 1717992
[TBL] [Abstract][Full Text] [Related]
28. Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin.
Yang X; Lee J; Mahony EM; Kwong PD; Wyatt R; Sodroski J
J Virol; 2002 May; 76(9):4634-42. PubMed ID: 11932429
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
30. Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis.
Ashkenazi A; Presta LG; Marsters SA; Camerato TR; Rosenthal KA; Fendly BM; Capon DJ
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7150-4. PubMed ID: 2402498
[TBL] [Abstract][Full Text] [Related]
31. The recognition of chimeras of rat and human CD4 by HIV-1 gp120 and by monoclonal antibodies.
Davis SJ; James WS; Schockmel GA; Simon JH; Somoza C
Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):75-81. PubMed ID: 7904351
[TBL] [Abstract][Full Text] [Related]
32. Characterization of T cell-expressed chimeric receptors with antibody-type specificity for the CD4 binding site of HIV-1 gp120.
Bitton N; Verrier F; Debré P; Gorochov G
Eur J Immunol; 1998 Dec; 28(12):4177-87. PubMed ID: 9862354
[TBL] [Abstract][Full Text] [Related]
33. Synergistic inhibition of HIV-1 envelope-mediated cell fusion by CD4-based molecules in combination with antibodies to gp120 or gp41.
Allaway GP; Ryder AM; Beaudry GA; Maddon PJ
AIDS Res Hum Retroviruses; 1993 Jul; 9(7):581-7. PubMed ID: 8369162
[TBL] [Abstract][Full Text] [Related]
34. A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities.
Babcook JS; Leslie KB; Olsen OA; Salmon RA; Schrader JW
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7843-8. PubMed ID: 8755564
[TBL] [Abstract][Full Text] [Related]
35. Animal pharmacokinetics of the tumor necrosis factor receptor-immunoglobulin fusion protein lenercept and their extrapolation to humans.
Richter WF; Gallati H; Schiller CD
Drug Metab Dispos; 1999 Jan; 27(1):21-5. PubMed ID: 9884305
[TBL] [Abstract][Full Text] [Related]
36. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
[TBL] [Abstract][Full Text] [Related]
37. A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies.
Stracke J; Emrich T; Rueger P; Schlothauer T; Kling L; Knaupp A; Hertenberger H; Wolfert A; Spick C; Lau W; Drabner G; Reiff U; Koll H; Papadimitriou A
MAbs; 2014; 6(5):1229-42. PubMed ID: 25517308
[TBL] [Abstract][Full Text] [Related]
38. Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction.
McKeating JA; Thali M; Furman C; Karwowska S; Gorny MK; Cordell J; Zolla-Pazner S; Sodroski J; Weiss RA
Virology; 1992 Sep; 190(1):134-42. PubMed ID: 1382339
[TBL] [Abstract][Full Text] [Related]
39. CD4-IgG binding threshold for inactivation of human immunodeficiency virus type 1.
Berkower I; Mostowski H; Bull TE; Murphy D
J Infect Dis; 1996 Apr; 173(4):863-9. PubMed ID: 8603964
[TBL] [Abstract][Full Text] [Related]
40. Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.
Liu L; Patel B; Ghanem MH; Bundoc V; Zheng Z; Morgan RA; Rosenberg SA; Dey B; Berger EA
J Virol; 2015 Jul; 89(13):6685-94. PubMed ID: 25878112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
